These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16363233)

  • 1. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Thromb Haemost; 2005 Nov; 94(5):933-41. PubMed ID: 16363233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibody.
    Mersich C; Billes W; Pabinger I; Jungbauer A
    Biotechnol Bioeng; 2007 Sep; 98(1):12-21. PubMed ID: 17390380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display technology: a tool to explore the diversity of inhibitors to blood coagulation factor VIII.
    Voorberg J; van den Brink EN
    Semin Thromb Hemost; 2000; 26(2):143-50. PubMed ID: 10919406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies.
    Kessel C; Kreuz W; Klich K; Becker-Peters K; Vorpahl F; Dietrich U; Klingebiel T; Königs C
    ChemMedChem; 2009 Aug; 4(8):1364-70. PubMed ID: 19533722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M; Branckaert T; Laub R
    Biologicals; 2001; 29(3-4):229-32. PubMed ID: 11851320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Biotechnol Bioeng; 2006 Mar; 93(4):647-55. PubMed ID: 16395719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors.
    Sawamoto Y; Prescott R; Zhong D; Saenko EL; Mauser-Bunschoten E; Peerlinck K; van den Berg M; Scandella D
    Thromb Haemost; 1998 Jan; 79(1):62-8. PubMed ID: 9459325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Kazatchkine MD; Kaveri SV
    Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of inhibitor development in hemophilia A.
    Fijnvandraat K; Bril WS; Voorberg J
    Semin Thromb Hemost; 2003 Feb; 29(1):61-8. PubMed ID: 12640567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
    Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
    Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.
    Ananyeva NM; Lacroix-Desmazes S; Hauser CA; Shima M; Ovanesov MV; Khrenov AV; Saenko EL
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):109-24. PubMed ID: 15090997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
    Albert T; Lange S; Oldenburg J; Graw J; Schramm W; Hanfland P; Brackmann HH; Schwaab R
    Hamostaseologie; 2003 Feb; 23(1):13-7. PubMed ID: 12567194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.